Glucose Buddy is a medical tracking app for diabetes management, allowing users to log blood glucose, medication, and health metrics on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#83
▲16Medical · grossing
Sentiment
3.9
39k reviews
Nemesis
mySugr - Diabetes Tracker Log
The App DNA
What makes this app unique?
It serves as a centralized health record for patients who need to share long-term A1C and glucose trends with their medical providers.
For Individuals managing diabetes who require consistent blood glucose tracking, meal logging, and professional health guidance.
What does it look like?
Key features
Manual entry for blood glucose, medication, insulin, weight, and activity levels.
Calculates long-term A1C trends based on logged glucose data, gated behind premium.
Direct sync with Agamatrix Jazz Wireless 2 meters for automated data capture.
How much does it cost?
Freemium model gates advanced analytics and ad-free usage behind a subscription, while offering high-touch coaching services as a primary revenue driver.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app ships approximately 0.06 releases per week, placing it firmly in the maintenance tier. Development is characterized by infrequent, generic updates focused on performance and stability rather than new features or live operations. The latest release continues this trend of opaque maintenance, with no evidence of active feature development or seasonal content cycles over the last 12 months.
Who built it?
Azumio
7 apps tracked · Medical
Glucose Buddy+ for Diabetes
Instant Fitness: Workout Trainer
Calorie Mama AI: Diet Counter
Argus: Pedometer Step Tracker
Sleep Time: Cycle Alarm Clock
Argus: Activity & Step TrackerUser Sentiment
What do users think recently?
Fresh user feedback skews frustrated. Users appreciate long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location and intuitive data visualization and export features help patients share health trends with their medical providers, but report critical stability issues post-update cause the application to freeze or display a blank loading screen.
How are ratings & reviews evolving?
What users say, by theme
- Long-term users value the comprehensive tracking of glucose, blood pressure, and weight in one location
- Intuitive data visualization and export features help patients share health trends with their medical providers
- Critical stability issues post-update cause the application to freeze or display a blank loading screen
95 of 509 recent reviews analyzed · high confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Glucose Buddy Diabetes Tracker
How's the Medical market?
Glucose Buddy holds a #51 Grossing position in the US Medical category, yet the 325-day average update cadence signals a shift into maintenance mode. This stagnation leaves the app vulnerable to high-velocity rivals that prioritize real-time data automation over manual logging.
The rivals identified
By mySugr GmbH
With over 134,000 reviews and a high-velocity release cadence, mySugr is the dominant direct competitor in the diabetes logging space.
- Gamified logging experience provides immediate positive reinforcement for consistent blood glucose data entry
- Deep integration with various continuous glucose monitors (CGM) automates data flow for power users
- High-frequency release cycle of 12 updates in six months ensures rapid feature iteration and stability
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Glucose Buddy Diabetes Tracker
Where is it heading?
The diabetes management market is consolidating around automated data streaming, leaving manual-entry tools like Glucose Buddy increasingly isolated. Without a shift to real-time CGM integration, the app will continue to lose market share to hardware-integrated rivals that provide higher clinical value with lower user effort.
- The 325-day update cadence indicates a shift to maintenance mode, which prevents the app from matching the rapid feature iteration of direct rivals.
- Persistent launch-day crashes post-update erode the daily logging habit, which directly accelerates churn among the core user base.
The SWOT
- 15-year market presence builds high trust for legacy users
- Consolidated dashboard reduces cognitive load for multi-metric tracking
- Native CGM integration would remove manual-entry friction
- Barcode scanning improvements would increase logging accuracy for daily users
Next best moves
Audit launch-day stability because crashes on launch are the top-cited churn driver → restore daily active habit
+ 1 more prioritized moveThe counter-intuitive read
The app's #51 Grossing rank is a liability, not an asset…
Read the full takeFeature gaps
Real-time CGM streaming (available in Libre by Abbott, missing here) +2
Since the last report: Technical instability and aggressive monetization have intensified, shifting the primary stability complaint to a transitional status and adding new weaknesses regarding paywall-blocked core functionality. The app's grossing rank improved slightly to #51, but this is now viewed as a liability tied to legacy revenue models rather than product growth.
Bottom line
Users report: The app's legacy trust is being liquidated by technical instability and aggressive monetization. Restoring stability is the only way to defend the current user base against high-velocity rivals that offer superior automated data capture.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated